Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Fintel reports that on April 29, 2025, TD Cowen downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Buy to Hold.

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant Novo Nordisk announced it will distribute its blockbuster GLP-1 weight loss ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

PEMBROKE PARK, Fla. – Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers.

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

Danish drugmaker Novo Nordisk has announced that it is expanding patient access to Wegovy (semaglutide) injection 2.4 mg in ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Thatch, the leading platform for modern, flexible health benefits, today announced the launch of the Thatch Marketplace, a curated ecosystem of health and wellness services that employees can access ...